$4.45
1.83% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US24477E1038
Symbol
DH

Definitive Healthcare Stock price

$4.45
+0.29 6.97% 1M
-1.17 20.82% 6M
-5.49 55.23% YTD
-3.54 44.31% 1Y
-25.65 85.22% 3Y
-38.84 89.72% 5Y
-38.84 89.72% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.08 1.83%
ISIN
US24477E1038
Symbol
DH

Key metrics

Market capitalization $514.08m
Enterprise Value $654.93m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 12.42
EV/Sales (TTM) EV/Sales 2.56
P/S ratio (TTM) P/S ratio 2.01
P/B ratio (TTM) P/B ratio 1.01
Revenue growth (TTM) Revenue growth 3.97%
Revenue (TTM) Revenue $255.85m
EBIT (operating result TTM) EBIT $-18.33m
Free Cash Flow (TTM) Free Cash Flow $52.73m
Cash position $305.39m
EPS (TTM) EPS $-3.11
P/E forward negative
P/S forward 2.05
EV/Sales forward 2.62
Short interest 5.23%
Show more

Is Definitive Healthcare a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Definitive Healthcare Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Definitive Healthcare forecast:

4x Buy
31%
8x Hold
62%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Definitive Healthcare forecast:

Buy
31%
Hold
62%
Sell
8%

Financial data from Definitive Healthcare

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
256 256
4% 4%
100%
- Direct Costs 91 91
8% 8%
35%
165 165
2% 2%
65%
- Selling and Administrative Expenses 93 93
8% 8%
36%
- Research and Development Expense 39 39
5% 5%
15%
33 33
61% 61%
13%
- Depreciation and Amortization 52 52
0% 0%
20%
EBIT (Operating Income) EBIT -18 -18
40% 40%
-7%
Net Profit -364 -364
100% 100%
-142%

In millions USD.

Don't miss a Thing! We will send you all news about Definitive Healthcare directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Definitive Healthcare Stock News

Neutral
Seeking Alpha
16 days ago
Definitive Healthcare Corp. (NASDAQ:DH ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Richard Booth - Chief Financial Officer Conference Call Participants Jenny Shen - BTIG George Hill - Deutsche Bank Anna Kruszenski - Barclays Bank Operator Welcome to Definitive Healthcare's Q3 2024 Ear...
Neutral
GlobeNewsWire
19 days ago
Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization
Neutral
GlobeNewsWire
about one month ago
Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement
More Definitive Healthcare News

Company Profile

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.

Head office United States
CEO Kevin Coop
Employees 830
Founded 2011
Website www.definitivehc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today